Home » Topics » Regulatory

Regulatory
RSS

U.K. introduction for Nasonex

May 29, 1997

Promising data from pivotal trials of Actiq reported at ASCO

May 26, 1997

Mylan receives FDA approval of generic captopril/hydrochlorothiazide

May 23, 1997

Mylan receives FDA approval for generic etodolac

May 22, 1997

Merck updates development of higher dose Zocor

May 21, 1997

SmithKline Beecham's Famvir receives U.K. approval for new indication

May 21, 1997

Gensia receives ANDA approval for etoposide injection

May 21, 1997

Roche seeks FDA approval for new formulation of saquinavir

May 14, 1997

Bristol-Myers Squibb launches Vagistat-1 as OTC in the U.S.

May 13, 1997

RPR receives FDA clearance for new indication of enoxaparin

May 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.